• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

润滑剂对卡介苗用于膀胱癌膀胱内免疫治疗时活力的影响。

The effect of lubricants on viability of bacillus Calmette-Guerin for intravesical immunotherapy against bladder carcinoma.

作者信息

Böhle A, Rüsch-Gerdes S, Ulmer A J, Braasch H, Jocham D

机构信息

Department of Urology, Medical University of Lübeck, Germany.

出版信息

J Urol. 1996 Jun;155(6):1892-6.

PMID:8618281
Abstract

PURPOSE

The viability of bacillus Calmette-Guerin (BCG) is crucial for induction of a local immune response and for effective therapy of recurrent superficial bladder carcinoma. During intravesical instillation of BCG lubricants are administered to assist catheterization, which contain bacteriostatic components that may interfere with the viability of mycobacteria. To verify this assumption, 5 commercially available lubricants were analyzed with regard to inhibition of viable BCG growth.

MATERIALS AND METHODS

Five different lubricants and their components were co-incubated with Connaught strain BCG and the resultant growth of BCG was assessed. To prove the significant passage of lubricants into the bladder, fluid was recovered from the bladder after catheterization, analyzed with regard to the bacteriostatic effect and compared to normal urine of different acidity.

RESULTS

Significant impairment of BCG viability, dependent on dosage and time of co-incubation, was noted with all lubricants analyzed. Several components, namely lidocaine hydrochloride, glyceryl stearate, propyl-4-hydroxy-benzoate and chlorhexidine digluconate, were identified as responsible for this inhibition. Fluid recovered from the bladder after lubricant assisted catheterization also showed an inhibitory effect, indicating significant mixture of the instillate with lubricants.

CONCLUSIONS

Generous use of lubricants to assist catheterization during intravesical BCG therapy will result in a clinically significant decrease in the number of intravesically instilled viable mycobacteria. For this reason, during intravesical immunotherapy with BCG only small amounts of lubricants should be used for urethral catheterization, and use of catheters not requiring lubricants should be considered.

摘要

目的

卡介苗(BCG)的活性对于诱导局部免疫反应以及有效治疗复发性浅表性膀胱癌至关重要。在膀胱内灌注BCG期间,会使用润滑剂辅助插管,而这些润滑剂含有可能干扰分枝杆菌活性的抑菌成分。为证实这一假设,对5种市售润滑剂抑制BCG活菌生长的情况进行了分析。

材料与方法

将5种不同的润滑剂及其成分与康诺特菌株BCG共同孵育,并评估BCG的生长情况。为证明润滑剂能大量进入膀胱,插管后从膀胱回收液体,分析其抑菌效果,并与不同酸度的正常尿液进行比较。

结果

在所分析的所有润滑剂中,均发现BCG活性有显著损害,且损害程度取决于共同孵育的剂量和时间。确定了几种成分,即盐酸利多卡因、硬脂酸甘油酯、对羟基苯甲酸丙酯和葡萄糖酸洗必泰,是造成这种抑制作用的原因。润滑剂辅助插管后从膀胱回收的液体也显示出抑制作用,表明灌注液与润滑剂有大量混合。

结论

在膀胱内BCG治疗期间大量使用润滑剂辅助插管,将导致膀胱内灌注的活菌数在临床上显著减少。因此,在膀胱内BCG免疫治疗期间,尿道插管应仅使用少量润滑剂,并应考虑使用无需润滑剂的导管。

相似文献

1
The effect of lubricants on viability of bacillus Calmette-Guerin for intravesical immunotherapy against bladder carcinoma.润滑剂对卡介苗用于膀胱癌膀胱内免疫治疗时活力的影响。
J Urol. 1996 Jun;155(6):1892-6.
2
Do bacteriostatic urethral lubricants affect the clinical efficacy of intravesical bacillus Calmette-Guérin therapy?抑菌性尿道润滑剂会影响膀胱内卡介苗治疗的临床疗效吗?
Urology. 2001 May;57(5):900-5. doi: 10.1016/s0090-4295(01)00903-7.
3
The fate of bacillus Calmette-Guerin after intravesical instillation.卡介苗膀胱内灌注后的转归
J Urol. 2001 May;165(5):1765-8.
4
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.卡介苗维持免疫疗法用于复发性TA、T1期及原位膀胱移行细胞癌:西南肿瘤协作组的一项随机研究
J Urol. 2000 Apr;163(4):1124-9.
5
Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.卡介苗膀胱灌注治疗浅表性膀胱癌期间尿液细胞因子:处理、稳定性及预后价值
J Urol. 1996 Feb;155(2):477-82.
6
A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.膀胱内注射阿霉素与卡介苗免疫疗法治疗膀胱移行细胞癌的随机试验。
N Engl J Med. 1991 Oct 24;325(17):1205-9. doi: 10.1056/NEJM199110243251703.
7
[Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].[卡介苗膀胱内灌注治疗膀胱原位癌。岐阜卡介苗灌注治疗研究组]
Gan To Kagaku Ryoho. 1999 Oct;26(12):1869-73.
8
[ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder].[免疫膀胱内灌注剂(由卡介苗康诺特菌株制成的冻干制剂)用于治疗浅表性膀胱癌和膀胱原位癌]
Gan To Kagaku Ryoho. 2003 Jul;30(7):1027-38.
9
[Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].卡介苗诱导性膀胱灌注对膀胱癌术后复发的预防作用
Ai Zheng. 2008 Nov;27(11):1208-11.
10
Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.结核性前列腺脓肿作为膀胱内卡介苗免疫治疗的一种并发症。
Int J Urol. 2005 Oct;12(10):920-1. doi: 10.1111/j.1442-2042.2005.01183.x.

引用本文的文献

1
Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer.卡介苗治疗前门诊针刺治疗高危非肌层浸润性膀胱癌患者的1/2期随机临床试验
Eur Urol Oncol. 2024 Dec;7(6):1431-1440. doi: 10.1016/j.euo.2024.04.002. Epub 2024 Apr 22.
2
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.癌症免疫治疗学会共识声明:免疫疗法治疗膀胱癌。
J Immunother Cancer. 2017 Aug 15;5(1):68. doi: 10.1186/s40425-017-0271-0.
3
Lung cancer patients with previous or simultaneous urologic cancers.
既往或同时患有泌尿系统癌症的肺癌患者。
Med Oncol. 2008;25(4):443-6. doi: 10.1007/s12032-008-9063-1. Epub 2008 Apr 5.